Pfizer Ltd.

PFIZER

Market Cap
₹19,959 Cr.
P/E
39.75

Pfizer Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

8 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

1 No Data

Insufficient data to analyse

ROE
Latest
19.45%
3yr Average
20.54%
5yr Average
18.17%
Net Profit Margin
Latest
25.73%
3yr Average
23.81%
5yr Average
23.14%
ROCE
Latest
24.79%
3yr Average
26.17%
5yr Average
23.74%
Debt to Equity
Latest
0.0
3yr Average
0.0
5yr Average
0.0
Market Share
17% (as of Mar 23)
Antacid (Gelucil) - Market Share
locked Source
0% (as of Jul 22)
Anti - Diabetes - Market Share
2.98% (as of Jul 22)
Anti-Infectives - Market Share
0.14% (as of May 19)
Anti-Malarial - Market Share
67% (as of Mar 23)
Anticholinergics ( Pacitane) - Market Share
locked Source
2.34% (as of Nov 21)
Antineo Plastic - Market Share
75.10% (as of Mar 21)
Becosules - Market Share
locked Source
6.08% (as of Nov 21)
Blood Related - Market Share
1.88% (as of Jul 22)
Cardiovascular - Market Share
39% (as of Mar 19)
Cefoperazone Sulbactam - Market Share
locked Source
15.30% (as of Mar 23)
Corex Dx - Market Share
locked Source
0.05% (as of Nov 21)
Dermatology - Market Share
29.70% (as of Mar 22)
Eliquis - Market Share
locked Source
30% (as of Mar 19)
Enbrel - Market Share
locked Source
11.34% (as of Nov 21)
Endocrinology - Market Share
7.50% (as of Mar 19)
Folvite - Market Share
locked Source
1.82% (as of Jul 22)
Gastro-Intestinal - Market Share
4.45% (as of Nov 21)
Gynecology - Market Share
45% (as of Mar 23)
Hypertension (Minipress) - Market Share
locked Source
1% (as of Mar 19)
Lyrica - Market Share
locked Source
6.70% (as of Mar 23)
Magnex - Market Share
locked Source
5.50% (as of Mar 23)
Meronem - Market Share
locked Source
2.72% (as of Nov 21)
Neurological - Market Share
1.15% (as of Nov 21)
Ophthalmology - Market Share
1.78% (as of Nov 21)
Pain - Market Share
1.70% (as of Dec 22)
Pharmaceutical Sector - Market Share
1.87% (as of Nov 21)
Respiratory - Market Share
1.96% (as of Jul 22)
Sex Stimulants - Market Share
0.01% (as of Nov 21)
Stomatological - Market Share
2.40% (as of Nov 21)
Urology - Market Share
3.58% (as of Jul 22)
Vaccines - Market Share
2.66% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source
    Peer Comparison
    Brands
    Autrin
    Becosules
    Corex Dx
    Gelusil
    Ovral L
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline